The effect of the antimicrobial peptide, Dhvar-5, on gentamicin release from a polymethyl methacrylate bone cement

Biomaterials

Volumn 26, Issue 28, 2005, Pages 5717-5726

  Faber, C ^a,b   Hoogendoorn, R J W ^a   Lyaruu, D M ^b   Stallmann, H P ^a,b   Van Marle, J ^c   Van Nieuw Amerongen, A ^b   Smit, T H ^a   Wuisman, P I J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial peptide; Dhvar 5; Drug release; Gentamicin; Polymethylmethacrylate; Porosity

Indexed keywords

ANTIMICROBIAL PEPTIDES; GENTAMICIN; GENTAMICIN SULPHATES; MERCURY INTRUSION;

ANTIBIOTICS; COMPRESSIVE STRENGTH; CRYSTALS; MERCURY (METAL); MICROBIOLOGY; MICROPOROSITY; NITROGEN COMPOUNDS; POLYMETHYL METHACRYLATES;

BONE CEMENT;

ANTIMICROBIAL PEPTIDE DHVAR 5; GENTAMICIN; GENTAMICIN BONE CEMENT; MERCURY; PEPTIDE DERIVATIVE; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG;

ARTICLE; COMPRESSIVE STRENGTH; DRUG RELEASE; KINETICS; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STATISTICAL SIGNIFICANCE;

ANTIMICROBIAL CATIONIC PEPTIDES; BONE CEMENTS; COATED MATERIALS, BIOCOMPATIBLE; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DIFFUSION; GENTAMICINS; MATERIALS TESTING; POLYMETHYL METHACRYLATE; SALIVARY PROTEINS;

EID: 18144423867     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2005.01.036     Document Type: Article

References (24)

1. H.W. Buchholz, and H. Engelbrecht Depot effects of various antibiotics mixed with Palacos resins Chirurg 41 11 1970 511 515
2. G. Josefsson, and L. Kolmert Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips Clin Orthop 292 1993 210 214
3. J. Hill, L. Klenerman, S. Trustey, and R. Blowers Diffusion of antibiotics from acrylic bone-cement in vitro J Bone Jt Surg Br 59 2 1977 197 199
4. L. Sanzen, and M. Walder Antibiotic resistance of coagulase-negative staphylococci in an orthopaedic department J Hosp Infect 12 2 1988 103 108
5. M.M. Tunney, G. Ramage, S. Patrick, J.R. Nixon, P.G. Murphy, and S.P. Gorman Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery Antimicrob Agents Chemother 42 11 1998 3002 3005
6. H. van de Belt, D. Neut, J.R. van Horn, H.C. van der Mei, W. Schenk, and H.J. Busscher...or not to treat? Nat Med 5 4 1999 358 359
7. P. Frutos, E. Diez-Pena, G. Frutos, and J.M. Barrales-Rienda Release of gentamicin sulphate from a modified commercial bone cement. Effect of (2-hydroxyethyl methacrylate) comonomer and poly(N-vinyl-2-pyrrolidone) additive on release mechanism and kinetics Biomaterials 23 18 2002 3787 3797
8. M.R. Virto, P. Frutos, S. Torrado, and G. Frutos Gentamicin release from modified acrylic bone cements with lactose and hydroxypropylmethylcellulose Biomaterials 24 1 2003 79 87
9. C. Faber, H.P. Stallmann, D.M. Lyaruu, J.M. de Blieck, T.J. Bervoets, and A.V. Nieuw Amerongen Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads J Antimicrob Chemother 51 6 2003 1359 1364
10. R.E. Hancock Peptide antibiotics Lancet 349 9049 1997 418 422
11. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 6870 2002 389 395
12. E.J. Helmerhorst, P. Breeuwer, W. Van't Hof, E. Walgreen-Weterings, L.C. Oomen, and E.C. Veerman The cellular target of histatin 5 on Candida albicans is the energized mitochondrion J Biol Chem 274 11 1999 7286 7291
13. A.L. Ruissen, J. Groenink, E.J. Helmerhorst, E. Walgreen-Weterings, W. van 't Hof, and E.C. Veerman Effects of histatin 5 and derived peptides on Candida albicans Biochem J 356 Pt 2 2001 361 368
14. W. van 't Hof, E.C. Veerman, E.J. Helmerhorst, and A.V. Nieuw Amerongen Antimicrobial peptides: properties and applicability Biol Chem 382 4 2001 597 619
15. D. Lyaruu, W. van 't Hof, E.C. Veerman, E.H. Burger, and A.V. Nieuw Amerongen Anti-microbial activity of human saliva histatin analogues against methicillin-resistant S. aureus (MRSA) J Dent Res 79 2000 227
16. C. Faber, R.J. Hoogendoorn, H.P. Stallmann, D.M. Lyaruu, A.A. van Nieuw, and P.I. Wuisman In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model J Antimicrob Chemother 2005 in press
17. H. Wahlig, E. Dingeldein, R. Bergmann, and K. Reuss The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study J Bone Jt Surg Br 60-B 2 1978 270 275
18. H. van de Belt, D. Neut, D.R. Uges, W. Schenk, J.R. van Horn, and H.C. van der Mei Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release Biomaterials 21 19 2000 1981 1987
19. E.P. Lautenschlager, J.J. Jacobs, G.W. Marshall, and P.R. Meyer Jr. Mechanical properties of bone cements containing large doses of antibiotic powders J Biomed Mater Res 10 6 1976 929 938
20. W. Van't Hof, M. van den Berg, P.C. Driedijk, and R.C. Aalberse Heterogeneity in the IgE binding to a peptide derived from the house dust mite allergen Der p II indicates that the IgE response is highly polyclonal Int Arch Allergy Immunol 101 4 1993 437 441
21. Implants for surgery - acrylic resin cements. ISO 5833 2002; Annex E.
22. H.P. Stallmann, C. Faber, E.T. Slotema, D.M. Lyaruu, A.L. Bronckers, and A. van Nieuw Amerongen Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes J Antimicrob Chemother 52 5 2003 853 855
23. K.A. Mehta, M.S. Kislalioglu, W. Phuapradit, A.W. Malick, and N.H. Shah Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug J Control Release 63 1-2 2000 201 211
24. W. Van 't Hof, I.M. Reijnders, E.J. Helmerhorst, E. Walgreen-Weterings, I.M. Simoons-Smit, and E.C. Veerman Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity Antonie Van Leeuwenhoek 78 2 2000 163 169